M. Nakajima

发表

Endothelin generating pathway through endothelin1–31 in human cultured bronchial smooth muscle cells

T. Iwasaki, Y. Hayasaki-Kajiwara, N. Naya, 1999, British journal of pharmacology.

EFFECTS OF LOSARTAN AND BENAZEPRILON ABNORMAL CIRCADIAN BLOODPRESSURE RHYTHM AND TARGETORGAN DAMAGE IN SHRSP

Y. Hayasaki-Kajiwara, N. Naya, T. Shimamura, 2002, Clinical and experimental hypertension.

α-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion

M. Ninomiya, M. Nakajima, K. Minagawa, 2000, Brain Research.

Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor

H. Tabuchi, K. Shiraki, M. Moriwaki, 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

Pharmacologic Characterization of S-1255, a Highly Potent and Orally Active Endothelin A Receptor Antagonist

M. Ninomiya, T. Iwasaki, Y. Hayasaki-Kajiwara, 2001, Journal of cardiovascular pharmacology.

Na+Influx via Na+/H+Exchange Activates Protein Kinase C Isozymesδ and ϵ in Cultured Neonatal Rat Cardiac Myocytes

T. Iwasaki, Y. Hayasaki-Kajiwara, N. Naya, 1999 .

Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.

T. Iwasaki, Y. Hayasaki-Kajiwara, N. Naya, 1999, Journal of cardiovascular pharmacology.

Normalization of retinal vascular permeability in experimental diabetes with genistein.

E. de Juan, M. Cooney, M. Melia, 2001, Investigative ophthalmology & visual science.

ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype.

T. Iwasaki, T. Shimamura, M. Nakajima, 1996, Biochemical and biophysical research communications.

Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.

T. Iwasaki, Y. Hayasaki-Kajiwara, N. Naya, 2000, European journal of pharmacology.

Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sites

H. Arita, M. Nakajima, K. Hanasaki, 1992, FEBS letters.

Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors.

Y. Aoyama, N. Naya, M. Nakajima, 2001, Bioorganic & medicinal chemistry.

Prophylactic effects of novel dihydropyrazolopyridine (83‐0256) and dihydrothienopyridine (83‐0312, 83‐0327) calcium antagonists in stroke‐prone spontaneously hypertensive rats

M. Nakajima, Hiroyuki Ito, M. Masui, 1990 .

Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.

Y. Aoyama, N. Naya, M. Nakajima, 2000, Bioorganic & medicinal chemistry letters.

Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.

Y. Aoyama, N. Naya, M. Nakajima, 2001, Bioorganic & medicinal chemistry letters.

Total synthesis of human chymase inhibitor methyllinderone and structure--activity relationships of its derivatives.

Y. Aoyama, N. Naya, M. Nakajima, 2001, Bioorganic & medicinal chemistry letters.

Microassay of cyclic nucleotides in vessel wall. II. Cyclic AMP phosphodiesterase activity.

M. Nakajima, F. Numano, K. Adachi, 1978, Microvascular research.

Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis.

N. Naya, M. Nakajima, 2002, Japanese Journal of Pharmacology.

1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma.

Y. Aoyama, N. Naya, M. Nakajima, 2000, Bioorganic & medicinal chemistry letters.

Actions of a Novel Thromboxane A2‐Receptor Antagonist, S‐145, on Isolated Monkey and Cat Arteries

M. Nakajima, M. Ueda, 1989, Journal of cardiovascular pharmacology.

Na(+)influx via Na(+)/H(+)exchange activates protein kinase C isozymes delta and epsilon in cultured neonatal rat cardiac myocytes.

T. Iwasaki, N. Naya, T. Shimamura, 1999, Journal of molecular and cellular cardiology.

Analysis of circadian blood pressure rhythm and target-organ damage in stroke-prone spontaneously hypertensive rats.

T. Iwasaki, T. Shimamura, M. Nakajima, 1999, Journal of hypertension.

Endothelium-independent vascular relaxation mediating ETB receptor in rabbit mesenteric arteries.

M. Ninomiya, T. Iwasaki, M. Notoya, 1999, American journal of physiology. Heart and circulatory physiology.

Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans.

T. Kusakabe, K. Nakao, Y. Fukuda, 2009, Obesity research & clinical practice.

Hypotensive and Prophylactic Effects of Angiotensin II Subtype 1 Receptor Antagonist, Irbesartan, in Stroke‐Prone Spontaneously Hypertensive Rats

T. Shimamura, M. Nakajima, M. Torii, 2004, Clinical and experimental hypertension.

Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries

N. Toda, M. Nakajima, T. Okamura, 1988, British journal of pharmacology.

Endothelin Receptor Antagonist Activity of (R)-(-)-2-(Benzo[l,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2- (6-methyl-2-propylpyridin-3-yloxy)acetamide Hydrochloride (PABSA) in Rat Aortic Smooth Muscle Cells and Isolated Rat Thoracic Aorta

T. Iwasaki, M. Nakajima, Y. Hayasaki‐Kajiwara, 2001, Arzneimittelforschung.